Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « ISSN » - entrée « 0392-856X »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0390-6078 < 0392-856X < 0394-6320  Facettes :

List of bibliographic references indexed by 0392-856X

Number of relevant bibliographic references: 103.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000031 (2020) Jerome Razanamahery [France] ; Sebastien Humbert [France] ; Helder Gil [France] ; Kevin Bouiller [France] ; Nadine Magy-Bertrand [France]Tropheryma Whipplei infection mimicking giant cell arteritis flare in a patient treated with interleukin-6 receptor blocker tocilizumab.
000065 (2020) Ian Pirker [Suisse] ; Andrea Rubbert-Roth [Suisse] ; Johannes Von Kempis [Suisse] ; Martin Fehr [Suisse] ; Thomas Neumann [Suisse]Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy.
000163 (2020) Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France]Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.
000D86 (2019) Selcan Demir [Turquie] ; Ozge Soyer [Turquie] ; Yelda Bilginer [Turquie] ; Erdal Sag [Turquie] ; Umit Murat Sahiner [Turquie] ; Betul Buyuktiryaki [Turquie] ; Bulent E. Sekerel [Turquie] ; Seza Ozen [Turquie]Desensitisation overcome rituximab- and tocilizumab-related immediate hypersensitivity in childhood.
000E84 (2019) Hiroaki Matsuno [Japon] ; Kou Katayama [Japon] ; Keiko Funahashi [Japon] ; Makoto Saitoh [Japon] ; Tsukasa Matsubara [Japon]Choice of the most appropriate biological disease-modifying rheumatic drug for injection spacing: results from a multicentre observational study.
001074 (2018) Bernard Combe [France] ; S. Lula ; C. Boone ; P. Durez [Belgique]Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review.
001364 (2018) M. Bombardieri [Royaume-Uni] ; C. Baldini [Italie] ; I. Alevizos [États-Unis] ; E. Akpek [États-Unis] ; A. N. Baer [États-Unis]Highlights of the 14th International Symposium on Sjögren’s Syndrome
003821 (2012) M. D. De Kruif [Pays-Bas] ; E. C. M. Van Gorp [Pays-Bas] ; E. H. Bel [Pays-Bas] ; D. M. Gerlag [Pays-Bas] ; P. W. Kunst [Pays-Bas]Streptococcal lung abscesses from a dental focus following tocilizumab: a case report
003825 (2012) C. Salvarani [Italie] ; L. Magnani [Italie] ; M. Catanoso [Italie] ; N. Pipitone [Italie] ; A. Versari [Italie] ; L. Dardani [Italie] ; L. Pulsatelli [Italie] ; R. Meliconi [Italie] ; L. Boiardi [Italie]Rescue treatment with Tocilizumab for Takayasu arteritis resistant to TNF-α blockers
003826 (2012) P. Urbaniak [Suisse] ; P. Hasler [Suisse] ; S. Kretzschmar [Suisse]Refractory neuro-Behçet treated by tocilizumab: a case report
003832 (2012) M. Bredemeier [Brésil] ; C. M. Rocha [Brésil] ; M. V. Barbosa [Brésil] ; E. H. Pitrez [Brésil]One-year clinical and radiological evolution of a patient with refractory Takayasu's arteritis under treatment with tocilizumab
003B91 (2011) E. Terpos [Grèce] ; K. Fragiadaki [Grèce] ; M. Konsta [Grèce] ; C. Bratengeier [Autriche] ; A. Papatheodorou [Grèce] ; P. P. Sfikakis [Grèce]Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis
003B92 (2011) H. Wakabayashi [Japon] ; H. Oka [Japon] ; Y. Nishioka [Japon] ; M. Hasegawa [Japon] ; A. Sudo [Japon] ; K. Nishioka [Japon]Do biologics-naïve patients with rheumatoid arthritis respond better to tocilizumab than patients for whom anti-TNF agents have failed? A retrospective study
003B97 (2011) A. Snir [Israël] ; A. Kessel [Israël] ; T. Haj [Israël] ; I. Rosner [Israël] ; G. Slobodin [Israël] ; E. Toubi [Israël]Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy
003E72 (2010) R. RauEfficacy of methotrexate in comparison to biologics in rheumatoid arthritis
004049 (2009) J. Braun [Allemagne] ; J. R. Kalden [Allemagne]Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis
004268 (1970-01-01) Laure Gossec [France] ; Ghislaine Steinberg ; Stephanie Rouanet [France] ; Bernard Combe [France]Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study.
004286 (????) Natasja St Hr Gudmann [Danemark] ; Peter Junker [Danemark] ; Pernille Juhl [Danemark] ; Christian Schneider Thudium [Danemark] ; Anne Sofie Siebuhr [Danemark] ; Inger Byrjalsen [Danemark] ; Morten Asser Karsdal [Danemark] ; Anne Christine Bay-Jensen [Danemark]Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis.
004289 (????) Eric Druyts [Canada] ; Jacqueline B. Palmer [États-Unis] ; Chakrapani Balijepalli [Canada] ; Keith Chan [Canada] ; Mir Sohail Fazeli [Canada] ; Vivian Herrera [États-Unis] ; Jeroen P. Jansen [Canada] ; Jay J H. Park [Canada] ; Steve Kanters [Canada] ; Andreas Reimold [États-Unis]Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression.
004294 (????) Fellipe Oliveira [États-Unis] ; Ronald R. Butendieck ; William W. Ginsburg ; Kimberly Parikh ; Andy AbrilTocilizumab, an effective treatment for relapsing giant cell arteritis.
004295 (????) Antonella Fioravanti [Italie] ; Sara Tenti [Italie] ; Maria Romana Bacarelli [Italie] ; Arianna Damiani [Italie] ; Francesca Li Gobbi [Italie] ; Francesca Bandinelli [Italie] ; Sara Cheleschi [Italie] ; Mauro Galeazzi [Italie] ; Maurizio Benucci [Italie]Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "0392-856X" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "0392-856X" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0392-856X
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021